Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 2 of 2
Full-Text Articles in Entire DC Network
Associations Between Covid-19 Therapies And Inpatient Gastrointestinal Bleeding: A Multisite Retrospective Study., Noah A. Wiedel, Harlan Sayles, Jessica Larson, Jana L. Wardian Phd, Alexander Hewlett, James C. Mcclay, Jin Ge, Alfred J. Anzalone, N3c Consortium
Associations Between Covid-19 Therapies And Inpatient Gastrointestinal Bleeding: A Multisite Retrospective Study., Noah A. Wiedel, Harlan Sayles, Jessica Larson, Jana L. Wardian Phd, Alexander Hewlett, James C. Mcclay, Jin Ge, Alfred J. Anzalone, N3c Consortium
Journal Articles: Hospital Medicine
Little data is available regarding the incidence of gastrointestinal bleeding in adults hospitalized with COVID-19 infection and the influence of patient comorbidities and demographics, COVID-19 therapies, and typical medications used. In this retrospective study, we utilized the National COVID Cohort Collaborative to investigate the primary outcome of the development of gastrointestinal bleeding in 512 467 hospitalized US adults (age >18 years) within 14 days of a COVID-19 infection and the influence of demographics, comorbidities, and selected medications. Gastrointestinal bleeding developed in 0.44% of patients hospitalized with COVID-19. Comorbidities associated with gastrointestinal bleeding include peptic ulcer disease (adjusted odds ratio [aOR] …
Associations Between Covid-19 Therapies And Inpatient Gastrointestinal Bleeding: A Multisite Retrospective Study, Noah A. Wiedel, Harlan Sayles, Jessica Larson, Jana L. Wardian Phd, Alexander Hewlett, James C. Mcclay, Jin Ge, Alfred J. Anzalone, The N3c Consortium
Associations Between Covid-19 Therapies And Inpatient Gastrointestinal Bleeding: A Multisite Retrospective Study, Noah A. Wiedel, Harlan Sayles, Jessica Larson, Jana L. Wardian Phd, Alexander Hewlett, James C. Mcclay, Jin Ge, Alfred J. Anzalone, The N3c Consortium
Journal Articles: Hospital Medicine
Little data is available regarding the incidence of gastrointestinal bleeding in adults hospitalized with COVID-19 infection and the influence of patient comorbidities and demographics, COVID-19 therapies, and typical medications used. In this retrospective study, we utilized the National COVID Cohort Collaborative to investigate the primary outcome of the development of gastrointestinal bleeding in 512 467 hospitalized US adults (age >18 years) within 14 days of a COVID-19 infection and the influence of demographics, comorbidities, and selected medications. Gastrointestinal bleeding developed in 0.44% of patients hospitalized with COVID-19. Comorbidities associated with gastrointestinal bleeding include peptic ulcer disease (adjusted odds ratio [aOR] …